Coenzyme A Stock Performance
| PPII Stock | USD 0.0002 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Coenzyme A are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Coenzyme A has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Coenzyme A is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor 1:500 | Last Split Date 2012-02-06 |
1 | Krstar Evening News Zhu Xiaohu Predicts China to Lead US in AI in Ten Years, Quark AI Glasses in Short Supply with New Production Lines Added, DingTalk 8.1.10 L... | 12/11/2025 |
Coenzyme A Relative Risk vs. Return Landscape
If you would invest 0.02 in Coenzyme A on September 27, 2025 and sell it today you would earn a total of 0.00 from holding Coenzyme A or generate 0.0% return on investment over 90 days. Coenzyme A is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Coenzyme, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Coenzyme A Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Coenzyme A's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Coenzyme A, and traders can use it to determine the average amount a Coenzyme A's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PPII |
Based on monthly moving average Coenzyme A is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Coenzyme A by adding Coenzyme A to a well-diversified portfolio.
Coenzyme A Fundamentals Growth
Coenzyme Stock prices reflect investors' perceptions of the future prospects and financial health of Coenzyme A, and Coenzyme A fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Coenzyme Stock performance.
| Operating Margin | (34.92) % | ||||
| Current Valuation | 397.18 K | ||||
| Shares Outstanding | 555.05 K | ||||
| Price To Sales | 0.0003 X | ||||
| Revenue | 325.46 K | ||||
| Gross Profit | 228.56 K | ||||
| EBITDA | (4.54 M) | ||||
| Net Income | (154.78 K) | ||||
| Cash And Equivalents | 35.53 K | ||||
| Cash Per Share | 0.07 X | ||||
| Total Debt | 419.28 K | ||||
| Book Value Per Share | (1.14) X | ||||
| Cash Flow From Operations | (4 K) | ||||
| Earnings Per Share | (35.31) X | ||||
| Total Asset | 79.08 K | ||||
| Retained Earnings | (742.76 K) | ||||
About Coenzyme A Performance
By evaluating Coenzyme A's fundamental ratios, stakeholders can gain valuable insights into Coenzyme A's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Coenzyme A has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Coenzyme A has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Coenzyme-A Inc. formulates and manufactures nutraceutical supplements, and skin and hair care products in the United States and internationally. Coenzyme-A Inc. was founded in 1998 and is based in Lynnwood, Washington. Coenzyme A operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Coenzyme A performance evaluation
Checking the ongoing alerts about Coenzyme A for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Coenzyme A help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Coenzyme A generated a negative expected return over the last 90 days | |
| Coenzyme A has some characteristics of a very speculative penny stock | |
| Coenzyme A has high likelihood to experience some financial distress in the next 2 years | |
| Coenzyme A currently holds 419.28 K in liabilities. Coenzyme A has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Coenzyme A's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 325.46 K. Net Loss for the year was (154.78 K) with profit before overhead, payroll, taxes, and interest of 228.56 K. | |
| Coenzyme A currently holds about 35.53 K in cash with (4 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Krstar Evening News Zhu Xiaohu Predicts China to Lead US in AI in Ten Years, Quark AI Glasses in Short Supply with New Production Lines Added, DingTalk 8.1.10 Launched with AI Auto - Reply Feature - 36Kr |
- Analyzing Coenzyme A's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Coenzyme A's stock is overvalued or undervalued compared to its peers.
- Examining Coenzyme A's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Coenzyme A's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Coenzyme A's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Coenzyme A's stock. These opinions can provide insight into Coenzyme A's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Coenzyme Stock analysis
When running Coenzyme A's price analysis, check to measure Coenzyme A's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coenzyme A is operating at the current time. Most of Coenzyme A's value examination focuses on studying past and present price action to predict the probability of Coenzyme A's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coenzyme A's price. Additionally, you may evaluate how the addition of Coenzyme A to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |